Cargando…
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
The presynaptic protein alpha-synuclein has received much attention because its gain-of-function is associated with Parkinson’s disease. However, its physiological function is still poorly understood. We studied brain regions of knock-out mice at different ages with regard to consistent upregulation...
Autores principales: | Kurz, Alexander, Rabbani, Naila, Walter, Michael, Bonin, Michael, Thornalley, Paul, Auburger, Georg, Gispert, Suzana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SP Birkhäuser Verlag Basel
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029823/ https://www.ncbi.nlm.nih.gov/pubmed/20711648 http://dx.doi.org/10.1007/s00018-010-0483-7 |
Ejemplares similares
-
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022) -
Complexin-1 and Foxp1 Expression Changes Are Novel Brain Effects of Alpha-Synuclein Pathology
por: Gispert, Suzana, et al.
Publicado: (2014) -
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
por: Rabbani, Naila, et al.
Publicado: (2016) -
A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP
por: Kurz, Alexander, et al.
Publicado: (2011) -
The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's disease
por: Auburger, Georg, et al.
Publicado: (2011)